These final results, together with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,two help the concept of targeting ACKR3 as a novel strategy to modulate the opioid system, which could open new therapeutic avenues for opioid-related disorders.By ticking this box and publishing this